N-cyclopropyl-1H-pyrazole-4-carboxamide, 98%, 250mg

1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 99.00%, 10g

Ethyl 5-cyclopropylisoxazole-3-carboxylate, 95.0%, 100mg

4-methyl-5-[(4-methylphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

METHYL 2-HYDROXY-4-(2,2,2-TRIFLUOROACETAMIDO)BENZOATE, 95.0%, 250mg

2,6-Difluoro-3-hydroxybenzaldehyde, 99.0%, 250mg

5-Amino-4-bromopyrimidine, 95.0%, 5g

5-(Bromomethyl)-2-fluorobenzoic acid, 98%, 1g

6-BROMO-3-(1-METHYL-1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE, 97.0%, 250mg

tert-Butyl (10-hydroxydecyl)carbamate, 97%, 100mg

tert-Butyl (5-(2-aminoethyl)thiazol-2-yl)carbamate, 95.0%, 500mg

4-Methylumbelliferyl 2-Acetamido-2-deoxy-beta-D-glucopyranoside>98.0%(HPLC)1g

Oxion Inverso material sciences OX.2153-PLM with LWD plan 5x/10x/20x objectives and LWD plan apochromatic 100x objective